Allopurinol versus usual care in UK patients with ischaemic heart disease (ALL-HEART): a multicentre, prospective, randomised, open-label, blinded-endpoint trial
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Allopurinol versus usual care in UK patients with ischaemic heart disease (ALL-HEART): a multicentre, prospective, randomised, open-label, blinded-endpoint trial
Authors
Keywords
-
Journal
LANCET
Volume 400, Issue 10359, Pages 1195-1205
Publisher
Elsevier BV
Online
2022-10-07
DOI
10.1016/s0140-6736(22)01657-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effectiveness of allopurinol on reducing mortality: Time‐related biases in observational studies
- (2021) Samy Suissa et al. Arthritis & Rheumatology
- Effect of serum urate lowering with allopurinol on blood pressure in young adults: A randomized, controlled, crossover trial
- (2021) Angelo L Gaffo et al. Arthritis & Rheumatology
- Febuxostat does not delay progression of carotid atherosclerosis in patients with asymptomatic hyperuricemia: A randomized, controlled trial
- (2020) Atsushi Tanaka et al. PLOS MEDICINE
- COVID-19 pandemic and admission rates for and management of acute coronary syndromes in England
- (2020) Marion M Mafham et al. LANCET
- A Randomized, Controlled Trial of the Effect of Allopurinol on Left Ventricular Mass Index in Hemodialysis Patients
- (2020) Elaine Rutherford et al. Kidney International Reports
- Febuxostat for Cerebral and CaRdiorenovascular Events PrEvEntion StuDy
- (2019) Sunao Kojima et al. EUROPEAN HEART JOURNAL
- Association between allopurinol and cardiovascular outcomes and all‐cause mortality in diabetes: A retrospective, population‐based cohort study
- (2019) Alanna Weisman et al. DIABETES OBESITY & METABOLISM
- Allopurinol treatment adversely impacts left ventricular mass regression in patients with well-controlled hypertension
- (2019) Christopher R. Gingles et al. JOURNAL OF HYPERTENSION
- Comparative cardiovascular risk in users versus non-users of xanthine oxidase inhibitors and febuxostat versus allopurinol users
- (2019) Chengsheng Ju et al. RHEUMATOLOGY
- Effects of losartan and allopurinol on cardiorespiratory regulation in obstructive sleep apnoea
- (2018) Barbara J. Morgan et al. EXPERIMENTAL PHYSIOLOGY
- Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout
- (2018) William B. White et al. NEW ENGLAND JOURNAL OF MEDICINE
- Case–control study examining the association between allopurinol use and ischemic cerebrovascular disease
- (2018) Shih-Wei Lai et al. JOURNAL OF INVESTIGATIVE MEDICINE
- Clinical Study on efficacy of allopurinol in patients with acute coronary syndrome and its functional mechanism
- (2017) Ying Huang et al. Hellenic Journal of Cardiology
- Allopurinol and Cardiovascular Outcomes in Adults With Hypertension
- (2016) Rachael L. MacIsaac et al. HYPERTENSION
- Multicentre, prospective, randomised, open-label, blinded end point trial of the efficacy of allopurinol therapy in improving cardiovascular outcomes in patients with ischaemic heart disease: protocol of the ALL-HEART study
- (2016) Isla S Mackenzie et al. BMJ Open
- Allopurinol reduces brachial and central blood pressure, and carotid intima-media thickness progression after ischaemic stroke and transient ischaemic attack: a randomised controlled trial
- (2014) P Higgins et al. HEART
- Effects of triple antioxidant therapy on measures of cardiovascular autonomic neuropathy and on myocardial blood flow in type 1 diabetes: a randomised controlled trial
- (2013) R. Pop-Busui et al. DIABETOLOGIA
- Allopurinol Reduces Left Ventricular Mass in Patients With Type 2 Diabetes and Left Ventricular Hypertrophy
- (2013) Benjamin R. Szwejkowski et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- High-Dose Allopurinol Reduces Left Ventricular Mass in Patients With Ischemic Heart Disease
- (2013) Sushma Rekhraj et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Mechanistic Insights Into the Therapeutic Use of High-Dose Allopurinol in Angina Pectoris
- (2011) Narasimharajapura S. Rajendra et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Allopurinol Benefits Left Ventricular Mass and Endothelial Dysfunction in Chronic Kidney Disease
- (2011) M. P. Kao et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Effect of high-dose allopurinol on exercise in patients with chronic stable angina: a randomised, placebo controlled crossover trial
- (2010) Awsan Noman et al. LANCET
- Effect of Allopurinol on Blood Pressure of Adolescents With Newly Diagnosed Essential Hypertension
- (2008) Daniel I. Feig et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started